Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Ahead of the MTG Lorwyn Eclipsed January 2026 launch, Wizards of the Coast revealed a wealth of cards that players can expect ...

Broadcom enters 2026 at an inflection point, with strong tailwinds from its ASIC and Networking segments. Read why AVGO stock ...

Overview Layer-3 blockchains are emerging as the next evolution in scaling beyond Layer-2, offering custom environments for ...

Digital asset regulation finally shifted into gear in 2025 as the US moved toward a more crypto-friendly legal framework and ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for the next decade.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Nvidia's restraint — focusing on enabling the ecosystem rather than owning it — has helped cement its role as the ...

One of the key learning outcomes of university education in general, and liberal arts programmes,  in particular, is that ...

Far beyond novelty or experiment, 2025 was the year that crossover projects rejected genre labels for endless sonic possibilities, writes Stewart Smith in The Wire 503/504 ...

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...